Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

British Journal of Cancer
J CuzickP Sasieni

Abstract

Human papillomavirus (HPV) vaccination has been approved in more than 90 countries and is being implemented in many of these. In the UK, vaccination for girls aged 12-13 with catch-up for girls up to age 18 was introduced in 2008, using the bivalent GSK vaccine (Cervarix). We modelled the proportion of abnormal smears, cervical intraepithelial neoplasia grade 3 (CIN3) and invasive cancer, which will be prevented in women aged 20-29 in the UK as a result of HPV vaccination. It will take many years for the full benefit of vaccination to be achieved. The earliest effects will be seen in women aged 20-29. With 80% coverage in women aged 12-13, we project an eventual 63% reduction in invasive cancer, a 51% reduction in CIN3 and a 27% reduction in cytological abnormalities before age 30. The full effect in this age group will not be seen until 2025, although half of the benefit will be seen by 2019 in England, where screening starts at age 25. However in Scotland and Wales, where screening starts at age 20, 50% of the benefit for CIN3 and abnormal smears (but not cancer) will be seen earlier. Substantial reductions in disease can be anticipated by vaccination, but most of the benefit will not be apparent for at least another decade. ...Continue Reading

References

Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Jun 30, 2001·JAMA : the Journal of the American Medical Association·A B MoscickiJ Palefsky
Dec 14, 2001·Lancet·K WellingsJ Field
Sep 26, 2002·Journal of the Royal Statistical Society. Series A, (Statistics in Society)·D BlaneM Rosato
Apr 7, 2005·Health Information and Libraries Journal·Lorraine McLeodAnn Wales
Apr 4, 2007·International Journal of Cancer. Journal International Du Cancer·Jennifer S SmithGary M Clifford
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
May 15, 2007·The New England Journal of Medicine·Suzanne M GarlandUNKNOWN Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
Oct 19, 2007·International Journal of Cancer. Journal International Du Cancer·Silvia Franceschi, Gary M Clifford
Dec 7, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gina S OgilvieDavid M Patrick
Feb 2, 2008·International Journal of Cancer. Journal International Du Cancer·Jack CuzickWilliam P Soutter
Mar 4, 2008·Journal of the National Cancer Institute·Jeremy D Goldhaber-FiebertSue J Goldie
Apr 9, 2008·British Journal of Cancer·A SargentUNKNOWN ARTISTIC Study Group
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Peter SasieniD Max Parkin
Oct 15, 2008·BMJ : British Medical Journal·Joakim DillnerUNKNOWN Joint European Cohort Study
Feb 19, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Helen TrottierUNKNOWN GSK HPV-001 Vaccine Study Group
Apr 24, 2010·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Doris M Rivera MedinaUNKNOWN HPV-013 Study Group

❮ Previous
Next ❯

Citations

May 3, 2014·PloS One·Eun-Kyeong MoonYoung-Joo Won
Aug 30, 2014·Archives of Pathology & Laboratory Medicine·Ann T MoriartyRhona Souers
Mar 24, 2011·BMC Public Health·Varun M Kumar, David K Whynes
Jul 12, 2011·The Journal of Infectious Diseases·Tjalke A WestraJan C Wilschut
Oct 6, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Simon Leeson
Oct 11, 2014·World Journal of Clinical Oncology·Shaniqua L McGraw, Jeanne M Ferrante
Aug 4, 2016·British Journal of Hospital Medicine·A MitraM Kyrgiou
Apr 26, 2012·International Journal of Cancer. Journal International Du Cancer·Cosette M WheelerUNKNOWN New Mexico HPV Pap Registry Steering Committee
Oct 1, 2011·Journal of Lower Genital Tract Disease·Mahmood I Shafi European Federation for Colposcopy
Oct 26, 2010·World Journal of Surgery·Seamus M McHughArnold D K Hill
Jul 25, 2013·British Journal of Cancer·E L LowU Menon
Feb 7, 2014·Der Radiologe·P M KazmierczakC C Cyran
Nov 3, 2017·British Journal of Cancer·Francesca PesolaPeter Sasieni
Jan 9, 2013·Archives of Gynecology and Obstetrics·Shuyu LongPei Yang
May 28, 2010·Journal of Medical Economics·Nadia Demarteau, Baudouin Standaert
Aug 9, 2011·Expert Review of Anti-infective Therapy·Julia M L Brotherton, Dorota M Gertig
Aug 26, 2011·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Trond Melbye Michelsen, Ole-Erik Iversen
Nov 30, 2011·Current Opinion in Obstetrics & Gynecology·Sun-Kuie Tay
Mar 8, 2016·Journal of Pediatric Hematology/oncology·Nathalie V BalmantBeatriz de Camargo
Apr 6, 2013·Sexual Health·Irwin LawFiona M Russell
Jun 16, 2012·Cancer Cytopathology·Ann T Moriarty
Jun 22, 2014·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·C Poethko-MüllerUNKNOWN KiGGS Study Group
Dec 14, 2018·BMC Women's Health·Ailie YoungMargaret Eleanor Cruickshank
Aug 2, 2013·The Journal of Family Planning and Reproductive Health Care·Harriet L BowyerJo Waller
May 20, 2016·Journal of Lower Genital Tract Disease·Yasmin L JayasingheJeffrey H J Tan
Nov 28, 2018·The Cancer Journal·Annalisa TramaEva Steliarova-Foucher
Jun 19, 2013·Journal of Lower Genital Tract Disease·Simon C LeesonK Ulrich Petry
Feb 2, 2021·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Simon LeesonChristine Bergeron
Mar 4, 2011·Archives of Pathology & Laboratory Medicine·Chengquan ZhaoR Marshall Austin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.